As of November 15, 2026, Ginkgo Bioworks Holdings, Inc. is a publicly traded company (NYSE: DNA); its largest reported holder is BlackRock, with 7.7% on Schedule 13G/A of July 30, 2026, then Cascade Investment, L.L.C. (7.5%). The largest insider holding is Reshma P. Shetty, a director and 10% owner, with 810,280 shares, per Form 4 of October 21, 2026 (Schedule 13G/A, July 30, 2026).
Is this your company?
About to sign with, pay or invest in Ginkgo Bioworks Holdings, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Ginkgo Bioworks Holdings, Inc. a real, registered company?
- Ginkgo Bioworks Holdings, Inc. files with the SEC under CIK 1830214 (its SEC filings).
- Its shares are listed under the ticker DNA on NYSE (SEC company record).
- Incorporated in Delaware; business address in Boston, Massachusetts, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Ginkgo Bioworks Holdings, Inc. in our court records and SEC 8-K records (as of 2026-11-15).
- Layoffs: 3 exit or restructuring plans reported on Form 8-K, Item 2.05 (latest filed 2024-08-08).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names BlackRock (filed 2026-07-30).
Who are Ginkgo Bioworks Holdings, Inc.'s owners and officers?
Ginkgo Bioworks Holdings, Inc.: incorporated in Delaware; business address in Boston, Massachusetts; industry Biological Products, (No Diagnostic Substances) (Schedule 13G/A, 2026-07-30).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-07-30 | Blackrock, Inc. | 7.7% |
| Schedule 13G/A, 2026-05-15 | Viking Global Investors LP | 7.1% |
| Schedule 13G/A, 2026-03-26 | The Vanguard Group | 0% |
| Schedule 13G/A, 2026-02-05 | Baillie Gifford & Co | 4.9% |
| Schedule 13G/A, 2025-11-14 | Cascade Investment, L.L.C. | 7.5% |
| Schedule 13G, 2025-07-29 | The Vanguard Group | 5.13% |
| Schedule 13G, 2025-07-17 | Blackrock, Inc. | 6.5% |
Questions about who owns Ginkgo Bioworks Holdings, Inc.
Who owns Ginkgo Bioworks Holdings, Inc.?
On this page, 3 holders' latest ownership filings report 5% or more of Ginkgo Bioworks Holdings, Inc.: Blackrock, Inc. (7.7%, Schedule 13G/A, filed 2026-07-30), Cascade Investment, L.L.C. (7.5%, Schedule 13G/A, filed 2025-11-14) and Viking Global Investors LP (7.1%, Schedule 13G/A, filed 2026-05-15).
Who are the largest shareholders of Ginkgo Bioworks Holdings, Inc.?
By the share each holder's latest filing reports, the largest holders of Ginkgo Bioworks Holdings, Inc. on this page are Blackrock, Inc. (7.7%), Cascade Investment, L.L.C. (7.5%) and Viking Global Investors LP (7.1%).
When did Blackrock, Inc. buy into Ginkgo Bioworks Holdings, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Blackrock, Inc. on this page is the Schedule 13G, filed 2025-07-17, reporting 6.5%; its latest, Schedule 13G/A filed 2026-07-30, reports 7.7%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 7 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Ginkgo Bioworks Holdings, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Ginkgo Bioworks Holdings, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Ginkgo Bioworks Holdings, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
15 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Ginkgo Bioworks Holdings, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a director and 10% owner: 810,280 shares, 453,951 held directly and 356,329 indirectly (Form 4, 2026-10-21).
- , a 10% owner: 810,280 shares, 356,329 held directly and 453,951 indirectly (Form 4, 2026-10-21).
- , a director: 271,418 shares (Form 4, 2025-06-13).
- , a director: 129,065 shares (Form 4, 2026-10-21).
- , a director: 72,372 shares (Form 4, 2025-06-13).
Shares only: the company's cover page does not give one share count for a single class, so no percentage is worked out.
How much has Ginkgo Bioworks Holdings, Inc. raised?
Acquisitions reported on Form 8-K, Item 2.01: completed an acquisition (2026-04-07).
Red flags found
3 exit or restructuring plans on Form 8-K (latest Form 8-K, 2024-08-08).
Keep reading
More on Ginkgo Bioworks Holdings, Inc. and the records around it.
Ginkgo Bioworks Holdings, Inc. elsewhere on the record
- Layoff notices Aug 2024
Companies that share a holder
- VIKING GLOBAL INVESTORS LP also filed stake reports on 27 other companies: City Therapeutics, Inc. (Oct 2026), MID AMERICA APARTMENT COMMUNITIES INC. (Oct 2026), REGAL REXNORD CORP (Sep 2026)
- BAILLIE GIFFORD & CO also filed stake reports on 39 other companies: QXO, Inc. (Oct 2026), Reddit, Inc. (Oct 2026), Samsara Inc. (Oct 2026)
- BlackRock, Inc. also filed stake reports on 1596 other companies: AvePoint, Inc. (Nov 2026), BIOMARIN PHARMACEUTICAL INC (Nov 2026), MSG RANGERS CORP (Nov 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/ginkgo-bioworks